NCT00087035 2020-08-03
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
3 trialsNCT00272038 2018-06-27
Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer
Oncology Specialists, S.C.
Phase 2 Completed
NCT00148772 2011-06-28
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
Endeavor Health
Phase 2 Completed